Quadrant Capital Group’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-335
| Closed | -$2.99K | – | 2484 |
|
|
2025
Q1 | $2.99K | Sell |
335
-697
| -68% | -$6.23K | ﹤0.01% | 2450 |
|
|
2024
Q4 | $9.71K | Buy |
1,032
+806
| +357% | +$7.59K | ﹤0.01% | 2136 |
|
|
2024
Q3 | $1.82K | Sell |
226
-763
| -77% | -$6.15K | ﹤0.01% | 2515 |
|
|
2024
Q2 | $8.39K | Buy |
989
+242
| +32% | +$2.05K | ﹤0.01% | 2171 |
|
|
2024
Q1 | $6.7K | Buy |
747
+461
| +161% | +$4.14K | ﹤0.01% | 2240 |
|
|
2023
Q4 | $3.22K | Buy |
286
+234
| +450% | +$2.63K | ﹤0.01% | 2378 |
|
|
2023
Q3 | $449 | Hold |
52
| – | – | ﹤0.01% | 2582 |
|
|
2023
Q2 | $539 | Hold |
52
| – | – | ﹤0.01% | 2561 |
|
|
2023
Q1 | $565 | Sell |
52
-76
| -59% | -$826 | ﹤0.01% | 2593 |
|
|
2022
Q4 | $1.44K | Sell |
128
-7
| -5% | -$79 | ﹤0.01% | 2478 |
|
|
2022
Q3 | $1K | Hold |
135
| – | – | ﹤0.01% | 2566 |
|
|
2022
Q2 | $1K | Sell |
135
-39
| -22% | -$289 | ﹤0.01% | 2452 |
|
|
2022
Q1 | $2K | Hold |
174
| – | – | ﹤0.01% | 2197 |
|
|
2021
Q4 | $2K | Buy |
174
+137
| +370% | +$1.58K | ﹤0.01% | 2186 |
|
|
2021
Q3 | $0 | Buy |
37
+12
| +48% | – | ﹤0.01% | 2643 |
|
|
2021
Q2 | $0 | Buy |
+25
| New | – | ﹤0.01% | 2555 |
|
|
2020
Q2 | – | Sell |
-1,693
| Closed | -$39K | – | 2390 |
|
|
2020
Q1 | $39K | Buy |
1,693
+8
| +0.5% | +$184 | 0.01% | 995 |
|
|
2019
Q4 | $43K | Hold |
1,685
| – | – | 0.01% | 1411 |
|
|
2019
Q3 | $32K | Buy |
+1,685
| New | +$32K | ﹤0.01% | 1417 |
|